Search Results 51-60 of 846 for Zepbound

  1. https://www.mayoclinic.org/chinese_condition_consolidated_concepts.xml

  2. A Study of the Effect of Liraglutide on Weight Loss and Stomach Functions in Obesity - Mayo Clinic

    About this study. Obesity is associated with differences in stomach function, feeling of fullness after meals, and total calories consumed at a buffet meal.

  3. Mayo Clinic Minute: What's the skinny on weight-loss drugs?

    Want to lose weight? It's really just basic math. Burn more calories than you take in. The best way to do that is by eating a healthy diet — reducing your ...

  4. Obesity - Doctors and departments - Mayo Clinic

    Bariatric Surgery & Weight Loss Discussions. mef46 · Beginning the Zepbound journey. 24 Replies Thu, Mar 26, 2026. Teresa, Volunteer Mentor · How do I eat after ...

  5. Ziftomenib (oral route) - Side effects & dosage - Mayo Clinic

    Ziftomenib is used to treat acute myeloid leukemia with nucleophosmin 1 (NPM1) mutation in patients whose disease has come back or did not respond to previous ...

  6. Pertuzumab-dpzb (intravenous route) - Side effects & uses - Mayo Clinic

    Pertuzumab-dpzb injection is used in combination with other cancer medicines (eg, trastuzumab, docetaxel) to treat HER2-positive metastatic (cancer that has ...

  7. Ezogabine (oral route) - Side effects & dosage - Mayo Clinic

    Ezogabine is used together with other medicines to control partial seizures (convulsions) in the treatment of epilepsy. Ezogabine belongs to a class of ...

  8. Pozelimab-bbfg (intravenous route, subcutaneous route) - Side effects & uses - Mayo Clinic

    Pozelimab-bbfg injection is used to treat a type of disease called CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease. This medicine ...

  9. Azathioprine (oral route) - Side effects & dosage - Mayo Clinic

    It is also used to relieve joint pain and swelling for patients with active rheumatoid arthritis. This medicine is available only with your doctor's ...

  10. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

    Inclusion Criteria: Signed informed consent. Either of the following: Completed the full treatment period of the lead-in trial (ZP1848-17111), regardless of ...